Latest Market Access News

Page 1 of 49
Sunrise Energy Metals has received unconditional FIRB approval for its proposed move to the United States, removing a key condition for the scheme. The company is targeting shareholder and Court approvals in January, with Nasdaq and ASX CDI trading expected to begin in February 2027.
Maxwell Dee
Maxwell Dee
19 Nov 2026
US Medicare has set a national outpatient payment of US$31,265 for Epiminder’s Minder System implant procedure from 1 January 2027, up 13% on the 2026 rate. The decision gives hospitals a defined reimbursement benchmark ahead of Epiminder’s planned US commercial launch.
Ada Torres
Ada Torres
6 Nov 2026
Proteomics International has launched a discounted A$5 million share purchase plan as it moves from product development into commercial rollout. Eligible shareholders can buy shares at A$0.10 and may receive a free attaching option, subject to approval.
Ada Torres
Ada Torres
2 Nov 2026
Environmental Clean Technologies says Xenica has secured a worldwide, non-exclusive Drexel University licence covering selected commercial MXene applications. The deal broadens the potential market beyond defence, but commercial revenue still depends on acquisition completion, repeatable production and customer qualification.
Victor Sage
Victor Sage
2 Nov 2026
Sunrise Energy Metals has approved development of its Syerston Scandium Project in New South Wales, targeting first commercial production in the second half of 2028. The decision moves the project into construction while leaving financing, listing and execution milestones ahead.
Maxwell Dee
Maxwell Dee
2 Nov 2026
Orthocell has recorded its strongest month of US Remplir sales since launch, with 92 units generating A$279,000 in October. The result points to improving surgeon adoption and hospital access, although one month of sales does not yet establish a durable run rate or profitability.
Victor Sage
Victor Sage
2 Nov 2026
Osteopore reported record quarterly revenue of A$859,000 in Q3 CY26 as it added market access in Thailand and Saudi Arabia and completed its first customised Hainan implant. The regenerative implant maker remains cash-flow negative, with A$712,000 in cash and A$14 million still available under its convertible note facility.
Victor Sage
Victor Sage
30 Oct 2026
Proteomics International has begun the national rollout of its Promarker D and Promarker Eso blood tests through Healius, while a A$2 million tax incentive receipt has lifted pro forma cash to A$3.8 million. Promarker Endo also cleared an independent Oxford validation hurdle, but its commercial launch remains conditional.
Ada Torres
Ada Torres
30 Oct 2026
Terragen has completed the induction of 10,600 cattle into its largest feedlot trial and secured Brazilian approval for its probiotic feed additive. But customer receipts fell to $255,000 for the September quarter, while cash declined to $5.73 million amid a CEO departure and chair transition.
Ada Torres
Ada Torres
30 Oct 2026
Comet Ridge has completed its Santos buyout, giving it full ownership and operatorship of the 677 PJ Mahalo Gas Hub resource base. The prize is greater control over a staged gas project, but $11.4 million of cash and incomplete funding arrangements leave a narrow runway ahead of a targeted mid-2027 investment decision.
Victor Sage
Victor Sage
30 Oct 2026
Epiminder has enrolled its 100th patient in the DETECT US epilepsy study ahead of schedule, while maintaining A$65.1 million in cash and no borrowings. The company says those reserves can fund clinical development and commercialisation work well into 2028.
Victor Sage
Victor Sage
30 Oct 2026
Wide Open Agriculture has completed the major physical steps in exiting its German manufacturing facility and is now testing four prospective Asian production partners. The transition could lower fixed costs, but commercial supply still depends on technical trials, partner selection and a definitive agreement.
Victor Sage
Victor Sage
30 Oct 2026

Browse the archive

Full archive